7/12 Noon Conference: Outpatient management of CHF

*Take home points: 1) The drugs that improve mortality in HFrEF are BB, ACEI, Spironolactone, and hydralazine/nitrates for African Americans. These drugs are NOT necessarily all helpful in HFpEF, HOCM, and valvular cardiomyopathy 2) Entresto = sacubitril/valsartan, an ARB/neprilysin inhibitor that may further improve mortality in chronic heart failure*
 
Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s